FDA approves Zydus Cadila's generic DiamoxZydus Cadila's acetazolamide is the generic of Teva's Diamox for injection. Wockhardt gets FDA nod for generic DacogenDecitabine had an annual market value of $120 million, according to February 2019 IQVIA data. Express Scripts’ Accredo specialty pharmacy expands in Hawaii Express Scripts' Accredo specialty pharmacy is scheduled to open in Honolulu this summer. Cipla, Pulmatrix reach agreement to develop Pulmazole The agreement enables Cipla’s entry into the branded specialty respiratory space. Lupin gets FDA green light for generic Prozac Fluoxetine tablets had an annual market value of roughly $68.2 million, according to December 2018 IQVIA data. ANI Pharmaceuticals deal boosts injectable portfolio ANI Pharmaceuticals has added a second specialty injectable product to its pipeline, the first product being Cortrophin gel. Teva launches generic AndroGel Testosterone gel 1.62% had an annual market value of more than $911 million, according to February 2019 IQVIA data. Rite Aid highlights MMR vaccine availability As of April 11, the Centers for Disease Control and Prevention have confirmed 555 cases of measles in the country. NACDS' Anderson urges drug abuse prevention bill sensitive to chronic pain patients’ needs The Hill published a column by NACDS president and CEO Steve Anderson on a bill that would serve as a “safety” mechanism for the use of opioids in treating temporary, or acute, pain. Janssen's Balversa gets FDA nod Janssen's Balversa is the first personalized treatment targeting susceptible genetic alternations for patients with metastatic bladder cancer. First Previous 480 481 482 483 484 Next Last
